Home/Filings/4/0001181431-13-012528
4//SEC Filing

Greve Jeffrey W. 4

Accession 0001181431-13-012528

CIK 0001369786other

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 8:08 PM ET

Size

5.3 KB

Accession

0001181431-13-012528

Insider Transaction Report

Form 4
Period: 2013-02-21
Greve Jeffrey W.
Vice President, Controller
Transactions
  • Award

    Stock Option to Buy

    2013-02-21+8,6048,604 total
    Exercise: $16.45Exp: 2023-02-21Common Stock (8,604 underlying)
Footnotes (1)
  • [F1]The option vests in four equal annual installments beginning on February 21, 2014.

Documents

1 file

Issuer

Sagent Pharmaceuticals, Inc.

CIK 0001369786

Entity typeother

Related Parties

1
  • filerCIK 0001544198

Filing Metadata

Form type
4
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 8:08 PM ET
Size
5.3 KB